Anticonvulsant hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro

Indian Journal of Medical Sciences

Volumn 60, Issue 2, 2006, Pages 59-63

  Karande, Sunil ^a   Gogtay, Nithya J ^b   Kanchan, Sandeep ^a   Kshirsagar, Nilima A ^a  

^a LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

^b KEM HOSPITAL   (India)

Author keywords

Anticonvulsant hypersensitivity syndrome; Lamotrigine; Lymphocyte toxicity assay

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANAMNESIS; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CELL DEATH; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; ELECTROENCEPHALOGRAM; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFANT; LABORATORY TEST; LYMPHOCYTE ACTIVATION; LYMPHOCYTOSIS; MACULOPAPULAR RASH; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TONIC CLONIC SEIZURE; TOXICITY TESTING; TREATMENT WITHDRAWAL;

EID: 33645308795     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5359.19914     Document Type: Article

References (12)

1. Alldredge BK, Knutsen AP, Ferriero D. Antiepileptic drug hypersensitivity syndrome: in vitro and clinical observations. Pediatr Neurol 1994;10:169-71.
2. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995;155:2285-90.
3. Bessmertny O, Hatton RC, Gonzalez-Peralta RP. Antiepileptic hypersensitivity syndrome in children. Ann Pharmacother 2001;35:533-8.
4. Farrell K, Connolly MB, Munn R, Peng S, MacWilliam LM. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy. Pediatr Neurol 1997;16:201-5.
5. Thome-Souza S, Freitas A, Fiore LA, Valente KD. Lamotrigine and valproate: efficacy of co-administration in a pediatric population. Pediatr Neurol 2003;28:360-4.
6. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988;82:1826-32.
7. Gogtay NJ, Bavdekar SB, Kshirsagar NA. Anticonvulsant hypersensitivity syndrome: a review. Expert Opin Drug Saf 2005;4:571-81.
8. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
9. Schlienger RG, Knowles SR, Shear NH. Lamotrigine-associated anticonvulsant hypersensitivity syndrome. Neurology 1998;51:1172-5.
10. Chattergoon DS, McGuigan MA, Koren G, Hwang P, Ito S. Multiorgan dysfunction and disseminated intravascular coagulation in children receiving lamotrigine and valproic acid. Neurology 1997;49:1442-4.
11. Brown TS, Appel JE, Kasteler JS, Callen JP. Hypersensitivity reaction in a child due to lamotrigine. Pediatr Dermatol 1999;16:46-9.
12. Schaub N, Bircher AJ. Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. Allergy 2000;55:191-3.